Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.

Cucchetti A, Trevisani F, Pecorelli A, Erroi V, Farinati F, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Giannini EG, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Baroni GS, Virdone R, Bernardi M, Pinna AD; Italian Liver Cancer Group.

J Hepatol. 2014 Aug;61(2):333-41. doi: 10.1016/j.jhep.2014.03.037. Epub 2014 Apr 6.

PMID:
24717522
2.

Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.

Del Poggio P, Olmi S, Ciccarese F, Di Marco M, Rapaccini GL, Benvegnù L, Borzio F, Farinati F, Zoli M, Giannini EG, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group.

Clin Gastroenterol Hepatol. 2014 Nov;12(11):1927-33.e2. doi: 10.1016/j.cgh.2014.02.025. Epub 2014 Feb 26.

PMID:
24582947
3.

Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

Santi V, Trevisani F, Gramenzi A, Grignaschi A, Mirici-Cappa F, Del Poggio P, Di Nolfo MA, Benvegnù L, Farinati F, Zoli M, Giannini EG, Borzio F, Caturelli E, Chiaramonte M, Bernardi M; Italian Liver Cancer (ITA.LI.CA) Group.

J Hepatol. 2010 Aug;53(2):291-7. doi: 10.1016/j.jhep.2010.03.010. Epub 2010 Apr 27.

PMID:
20483497
4.

Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population.

Cucchetti A, Trevisani F, Cescon M, Ercolani G, Farinati F, Poggio PD, Rapaccini G, Nolfo MA, Benvegnù L, Zoli M, Borzio F, Giannini EG, Caturelli E, Chiaramonte M, Pinna AD; Italian Liver Cancer (ITA.LI.CA) Group.

J Hepatol. 2012 May;56(5):1089-96. doi: 10.1016/j.jhep.2011.11.022. Epub 2012 Jan 13.

PMID:
22245900
5.

Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.

Cucchetti A, Piscaglia F, Caturelli E, Benvegnù L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD.

Ann Surg Oncol. 2009 Feb;16(2):413-22. doi: 10.1245/s10434-008-0232-4. Epub 2008 Nov 26.

PMID:
19034578
6.

Marginal survival benefit in the treatment of early hepatocellular carcinoma.

Midorikawa Y, Takayama T, Shimada K, Nakayama H, Higaki T, Moriguchi M, Nara S, Tsuji S, Tanaka M.

J Hepatol. 2013 Feb;58(2):306-11. doi: 10.1016/j.jhep.2012.09.026. Epub 2012 Oct 9.

PMID:
23063418
7.

Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?

Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M; Italian Liver Cancer Group.

Am J Gastroenterol. 2007 Nov;102(11):2448-57; quiz 2458. Epub 2007 Jul 7.

PMID:
17617210
8.

Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.

Singal AG, Pillai A, Tiro J.

PLoS Med. 2014 Apr 1;11(4):e1001624. doi: 10.1371/journal.pmed.1001624. eCollection 2014 Apr.

9.

Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.

Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, Nagaoka S, Akiyoshi J, Inoue K, Torimura T, Kumashiro R, Ueno T, Sata M.

J Clin Gastroenterol. 2006 Nov-Dec;40(10):942-8.

PMID:
17063116
10.

Surveillance for hepatocellular carcinoma.

Della Corte C, Colombo M.

Semin Oncol. 2012 Aug;39(4):384-98. doi: 10.1053/j.seminoncol.2012.05.002. Review.

PMID:
22846857
11.

Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J.

Clin Gastroenterol Hepatol. 2006 Sep;4(9):1170-6. Epub 2006 Aug 2.

PMID:
16890027
12.

Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.

Amarapurkar D, Han KH, Chan HL, Ueno Y; Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.

J Gastroenterol Hepatol. 2009 Jun;24(6):955-61. doi: 10.1111/j.1440-1746.2009.05805.x. Epub 2009 Mar 11.

PMID:
19383082
13.

[Early diagnosis and improved survival with screening for hepatocellular carcinoma].

Youk CM, Choi MS, Paik SW, Ahn BH, Lee JH, Koh KC, Yoo BC, Rhee JC.

Taehan Kan Hakhoe Chi. 2003 Jun;9(2):116-23. Korean.

14.

Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma.

Shindo K, Maekawa S, Komatsu N, Tatsumi A, Miura M, Sato M, Suzuki Y, Matsuda S, Muraoka M, Amemiya F, Fukasawa M, Yamaguchi T, Nakayama Y, Uetake T, Inoue T, Sakamoto M, Sato T, Enomoto N.

Mediators Inflamm. 2015;2015:687484. doi: 10.1155/2015/687484. Epub 2015 Sep 30.

15.

Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study.

Han KH, Kim DY, Park JY, Ahn SH, Kim J, Kim SU, Kim JK, Lee KS, Chon CY.

J Clin Gastroenterol. 2013 Jul;47(6):538-44. doi: 10.1097/MCG.0b013e3182755c13.

PMID:
23340065
16.

Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.

Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D'Onofrio M, Iacono C.

J Gastrointest Surg. 2012 Feb;16(2):301-11; discussion 311. doi: 10.1007/s11605-011-1745-x. Epub 2011 Nov 18.

PMID:
22095524
17.

Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway--a population-based cohort study.

Eskesen AN, Bjøro K, Aandahl EM, Line PD, Melum E.

Cancer Epidemiol. 2014 Dec;38(6):741-7.

PMID:
25454262
18.

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.

Ruzzenente A, Capra F, Pachera S, Iacono C, Piccirillo G, Lunardi M, Pistoso S, Valdegamberi A, D'Onofrio M, Guglielmi A.

J Gastrointest Surg. 2009 Jul;13(7):1313-20. doi: 10.1007/s11605-009-0903-x. Epub 2009 May 6.

PMID:
19418103
19.

[Hepatocellular carcinoma: risk groups--screening].

Maier KP.

Praxis (Bern 1994). 2002 Aug 28;91(35):1380-6. Review. German.

PMID:
12233279
20.

Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinoma.

Chan SL, Mo FK, Wong VW, Liem GS, Wong GL, Chan VT, Poon DM, Loong HH, Yeo W, Chan AT, Mok TS, Chan HL.

Liver Int. 2012 Feb;32(2):271-8. doi: 10.1111/j.1478-3231.2011.02634.x. Epub 2011 Aug 31.

PMID:
22098536

Supplemental Content

Support Center